Healthcare: Carl Icahn Takes Aim At Bristol-Myers Squibb
02/22/17 • 21 min
Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.
Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.
Previous Episode
CG: What to Watch in the Fast Food Industry
From price wars to automation, Fool.com contributor Daniel Kline offers his take on major trends currently driving innovation and growth at your favorite quick service restaurants.
Next Episode
Energy: The Companies Trying to Solve the Riddle of Energy Storage
Energy storage is a hot topic these days, here’s who is currently leading the charge.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/industry-focus-133361/healthcare-carl-icahn-takes-aim-at-bristol-myers-squibb-6557692"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to healthcare: carl icahn takes aim at bristol-myers squibb on goodpods" style="width: 225px" /> </a>
Copy